Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...

Tech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen ...

The series will give viewers a behind-the-scenes look into the Dallas-based company's use of DNA and genetic engineering, as well as document the lives of extinct animals like woolly mammoths and ...

Colossal Biosciences CEO Ben Lamm speaking at SXSW in Austin, Texas on March 9. Amy E. Price/SXSW Conference & Festivals via Getty Images The biotech aspect, which involves genetically engineering ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In a move that blurs the line between science fiction and reality, ...

EDITOR’S NOTE: Call to Earth is a CNN editorial series committed to reporting on the environmental challenges facing our planet, together with the solutions. Rolex’s Perpetual Planet Initiative has ...